UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025353
Receipt number R000029167
Scientific Title Study on improvement effect of men's menopausal symptoms due to food intake
Date of disclosure of the study information 2017/01/04
Last modified on 2019/02/26 20:12:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on improvement effect of men's menopausal symptoms due to food intake

Acronym

Effect of food on men's menopause

Scientific Title

Study on improvement effect of men's menopausal symptoms due to food intake

Scientific Title:Acronym

Effect of food on men's menopause

Region

Japan


Condition

Condition

late onset hypogonadism syndrome(LOH)

Classification by specialty

Endocrinology and Metabolism Urology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of improvement effect of men's menopausal symptoms due to intake of 5-aminolevulinic acid (ALA) containing foods and evaluation of safety

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Total serum testosterone
Testosterone in saliva
Sperm examination findings

Key secondary outcomes

AMS score (Aging males' symptoms score)
SF-36v2
IIEF score
Regarding safety, blood biochemical tests, urinalysis, adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

A tablet containing 10 mg of 5-aminolevulinic acid phosphate was administered 3 tablet daily for 8 weeks

Interventions/Control_2

placebo tablet intake group for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

75 years-old >

Gender

Male

Key inclusion criteria

1) Japanese male aged between 35 and 75 years old at the time of acquiring consent document of participation in the examination
2) men who have consciousness of indefinite complaint of menopausal male
3) AMS score of 27 points or more and less than 50 points
4) Those who have sufficient explanation about the purpose and contents of this exam, who have the capacity to consent, voluntarily volunteer for participation after understanding well, who can agree to participate in this study in writing
5) Men who can come to the designated examination date and receive examination
6) Men who the examination responsible doctor deems appropriate participation in this exam

Key exclusion criteria

1) Those who have had medical history of malignancy in the past 3 years
2) People who has a history history of heart failure, renal failure, hepatitis B, hepatitis C, current medical history
3) People whose AST (GOT), ALT (GPT) is 1.5 times or more the upper limit of the reference value
4) People whose PSA value is 4.0 ng / mL or more
5) People who have experienced severe allergic symptoms in foods and medicines
6) Health function foods (foods for specified health use, etc.), health foods, supplements with continuous ingestion habits, those who intend to intake during the examination period
7) People who judged that doctor is inappropriate as subject of this exam

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeo Horie

Organization

Juntendo University, Graduate School of Medicine

Division name

Department of Urology

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan 1138421

TEL

+81-3-5802-1227

Email

shorie@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiaki Wakumoto

Organization

Juntendo University, Graduate School of Medicine

Division name

Department of Urology

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan 1138421

TEL

+81-3-5802-1227

Homepage URL


Email

waku@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University, Graduate School of Medicine, Department of Urology

Institute

Department

Personal name



Funding Source

Organization

SBI ALA promo co.ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Juntendo University Urayasu Hospital, Teikyo University School of Medicine affiliated hospital, Men's Health Clinic Tokyo

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学大学院医学研究科


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 04 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry

2019 Year 02 Month 28 Day

Date trial data considered complete

2019 Year 02 Month 28 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 12 Month 21 Day

Last modified on

2019 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029167


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name